Health3 months ago
Rilzabrutinib Shows Promising Long-Term Benefits for ITP Patients
Rilzabrutinib has demonstrated sustained platelet responses and improved symptoms in patients with immune thrombocytopenia (ITP) according to long-term extension data from the LUNA 3 trial. Presented...
